Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIMPLIFY: Dextenza vs Topical Drops in Cataract Surgery
NCT04205916Phase 4Recruiting
- Sponsor
- Ophthalmic Consultants of Long Island
- Start
- Nov 2019
- Primary completion
- Jun 2020
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ozurdex in post-operative ocular inflammation and post-operative ocular pain, sponsored by Ophthalmic Consultants of Long Island. Started Nov 2019; status: recruiting.
02
Drugs
ozurdex
03
Conditions
post-operative ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on NCT04205916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04205916.